Ken Fisher, the billionaire investor known for mixing value investing with a spicy contrarian streak, is betting on UnitedHealth Group as a defensive stock darling. Fisher’s fund holds a $1.73 billion ...

North America Cancer Diagnostics Market Size Set Expands at Significant CAGR of 6.11% During 2024-2030 to Reach USD 23.48 Billion by 2030 Request To Download Free Sample of This Strategic Report @ ...

Resona Asset Management made a bold entrance into Citigroup’s investor circle by snagging 633,767 shares valued around $44.6 million. Several heavyweight hedge funds also boosted their stakes, ...

With a projected CAGR of 6.79% from 2024 to 2032, the global small animal imaging market is expected to see a significant rise in demand, leading to substantial improvements in research capabilities ...

We recently published a list of 10 Defensive Stocks Billionaire Ken Fisher is Betting On. In this article, we are going to ...

We recently published a list of 10 Defensive Stocks Billionaire Ken Fisher is Betting On. In this article, we are going to ...

Find insight on Microbix Biosystems, Lonza, China’s healthcare sector and more in the latest Market Talks covering the Health ...

Veteran investor Ken Fisher joins the growing list of billionaires who have criticized President Donald Trump's aggressive ...

RBC Capital lowered the firm’s price target on Thermo Fisher (TMO) to $651 from $694 and keeps an Outperform rating on the shares as part of a ...

In a report released yesterday, Kyle Menges from Citi maintained a Buy rating on Oshkosh (OSK – Research Report), with a price target of ...